INS and obesity disorder: The serum gas chromatography–mass spectrometry metabolomics phenotype of people with PCOS indicates a major role of obesity in the metabolic associations of this syndrome: while non-obese women with PCOS show evidence of central (hepatic) insulin resistance, peripheral insulin sensitivity is conserved in this subset of patients, whereas adipose and muscle insulin resistance only develops in obese patients [12].